BOSTON--(BUSINESS WIRE)--Flex Pharma, Inc., a biopharmaceutical company dedicated to creating innovative, novel treatments for neuromuscular disorders, announced today positive clinical results of its proprietary product for preventing muscle cramps. The Company expects to present the complete results at a future medical meeting.
The human studies consisted of two randomized, blinded, placebo-controlled crossover designs including a total of 40 enrolled subjects. The primary endpoint of each study was to evaluate the efficacy of the product in preventing muscle cramps. Each of the studies showed statistically significant results (p<0.0001), demonstrating that the proprietary product reduced electrically induced muscle cramps in minutes, and its effect lasted for hours compared to untreated subjects.
Help employers find you! Check out all the jobs and post your resume.
